NLRP3 and Alzheimer disease: In addition, omega-3 supplementation decreases NLRP3 activation via NF-κB, and decreases the expression of Th2 cytokines in experimental mouse models of AD, suggesting that this receptor is a target for therapeutic strategies for the disease.107